Clinical Trial Update: Pharmacogenetic Trial of Doxazosin for Treatment of Cocaine Abuse [Phase 2]

View source ↗

Summary

Phase 2 pharmacogenetic trial of doxazosin for cocaine dependence has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Dependence

Drugs mentioned

• Doxazosin (doxazosin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Cocaine Dependence | Phase 2 | Status: COMPLETED | Results posted: 2020-02-20